M
10b5-1 Plan
$ Value
$36K
Shares
3,000
Price
$12
Filed
Apr 2
Insider
Name
Karydas Daphne
Title
—
CIK
0001816952
Roles
Director
Transaction Details
Transaction Date
2026-03-31
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,200
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025. | The stock option vests in 36 monthly installments beginning on October 13, 2023.
Filing Info
Karydas Daphne's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MLYS | M | $36K |
| 2026-03-31 | MLYS | ▼ | $75K |
| 2026-03-31 | MLYS | M | $0 |
| 2025-11-13 | MLYS | M | $153K |
| 2025-11-13 | MLYS | ▼ | $463K |
| 2025-11-13 | MLYS | ▼ | $226K |
| 2025-11-13 | MLYS | M | $0 |
| 2025-06-12 | CMPS | A | $0 |
Other Insiders at MLYS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $8.8M | — | 2026-03-30 |
|
Congleton Jon
Chief Executive Officer
|
— | $2.4M | 2026-04-13 |
|
Rodman David Malcom
Chief Medical Officer
|
— | $621K | 2026-04-17 |
| Karydas Daphne | — | $75K | 2026-03-31 |